Life Technologies’ Q2 Hurt by Revamping of China Sales Strategy

Life Technologies, the San Diego biotechnology tools company, reported its Q2 results took a 2% hit because of a restructuring of the company’s China sales strategy. During Q2, Life Technologies began to add a direct sales force in China to its existing network of independent dealers. Some dealers were eliminated. When the affected dealers heard they would not be included in the revamped network, they began destocking their Life Technologies inventory. The order slowdown reduced revenues by about $18 million. More details.... Stock Symbol: (NSDQ: LIFE)     Share this with colleagues: